Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Tag
  • C-His-Avi
    (11)
  • N-6xHis
    (6)
  • Tag Free
    (4)
  • GST
    (2)
  • His
    (2)
  • C-His
    (1)
  • N-10xHis
    (1)
  • N-6xHis-SUMO
    (1)
  • N-GST
    (1)
  • N-His
    (1)
TargetMol | Tags By Expression System
  • E. coli
    (16)
  • HEK293 Cells
    (7)
  • Baculovirus Insect Cells
    (5)
TargetMol | Tags By Species
  • Human
    (18)
  • Gadus morhua
    (4)
  • Mouse
    (4)
  • E. coli
    (1)
  • Gadus callarias
    (1)
TargetMol | Tags By SPR-compatible Buffer
  • Buffer exchange required
    (15)
  • Ready-to-use
    (13)
Filter
Search Result
Results for "

gad

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    46
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    11
    TargetMol | Peptide_Products
  • Dye Reagents
    2
    TargetMol | Dye_Reagents
  • Natural Products
    5
    TargetMol | Natural_Products
  • Recombinant Protein
    28
    TargetMol | Recombinant_Protein
  • Isotope Products
    2
    TargetMol | Isotope_Products
TargetMolTargetMolCompare
GAD67 Protein, Human, Recombinant (His)
SCP, glutamate decarboxylase 1 (brain, 67kDa), GAD, CPSQ1
TMPY-02091
Expression system: Baculovirus Insect Cells
Length: 1-594, Full Length
Activity: Not Tested
  • Inquiry Price
7-10 days
Size
QTY
TargetMolTargetMolCompare
Gad c 1 Protein, Gadus morhua, Recombinant
TMPY-06883
Gad c 1 Protein, Gadus morhua, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 13.06 kDa.
    7-10 days
    Inquiry
    TargetMolTargetMolCompare
    Gad m 1 Protein, Gadus morhua, Recombinant
    TMPY-06925
    Gad m 1 Protein, Gadus morhua, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 12.28 kDa.
      7-10 days
      Inquiry
      TargetMolTargetMolCompare
      GAD-alpha Protein, E. coli, Recombinant (His)
      Glutamate decarboxylase alpha, gadS, GAD-alpha, gadA
      TMPH-00627
      Expression system: E. coli
      Length: 1-466, Full Length
      Activity: Not Tested
      • Inquiry Price
      20 days
      Size
      QTY
      TargetMolTargetMolCompare
      UCHL1 Protein, Mouse, Recombinant (His)
      UCHL-1, UCH-L1, ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase), R75593, PGP9.5, gad, C88048, AW822034
      TMPY-02175
      Expression system: E. coli
      Length: 2-223, Partial
      Activity: Enzyme activity
      • Inquiry Price
      7-10 days
      Size
      QTY
      TargetMolTargetMolCompare
      GAD2/GAD65 Protein, Human, Recombinant (GST)
      glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa), GAD65
      TMPY-04699
      GAD65 Protein, Human, Recombinant (GST) is expressed in Baculovirus insect cells with GST tag. The predicted molecular weight is 92.6 kDa and the accession number is Q05329.
      • Inquiry Price
      7-10 days
      Size
      QTY
      TargetMol | Inhibitor Sale
      TargetMolTargetMolCompare
      GAD2/GAD65 Protein, Mouse, Recombinant
      glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa), GAD65, Gad-2, GAD(65), 6330404F12Rik
      TMPY-03515
      Expression system: Baculovirus Insect Cells
      Length: 1-585, Full Length
      Activity: Not Tested
      • Inquiry Price
      7-10 days
      Size
      QTY
      TargetMolTargetMolCompare
      GAD2/GAD65 Protein, Mouse, Recombinant (His & GST)
      glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa), GAD65, Gad-2, GAD(65), 6330404F12Rik
      TMPY-01590
      Expression system: Baculovirus Insect Cells
      Length: 1-585, Full Length
      Activity: Not Tested
      • Inquiry Price
      7-10 days
      Size
      QTY
      TargetMolTargetMolCompare
      GAD2/GAD65 Protein, Mouse, Recombinant (His)
      Glutamate decarboxylase 65 kDa isoform, Glutamate decarboxylase 2, Gad65, Gad2, 65 kDa glutamic acid decarboxylase (GAD-65)
      TMPH-04492
      GAD2 GAD65 Protein, Mouse, Recombinant (His) is expressed in E. coli. The accession number is P48320.
      • Inquiry Price
      20 days
      Size
      QTY
      SPR-compatible buffer
      TargetMolTargetMolCompare
      Parvalbumin beta Protein, Gadus morhua subsp. callarias, Recombinant (His)
      Parvalbumin beta, Allergen M, Allergen Gad c I
      TMPH-00763
      Expression system: E. coli
      Length: 1-113, Full Length
      Activity: Not Tested
      • Inquiry Price
      20 days
      Size
      QTY
      TargetMolTargetMolCompare
      HLA-C 03:04&B2M&KRAS G12D (GADGVGKSAL) Monomer Protein, Human, MHC (His & Avi)
      RASK2, RALD, NS3, NS, MHC, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-Ras 2, KRAS, KI-RAS, GTPase Kras, C-K-RAS, CFC2
      TMPK-01451
      Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
      • Inquiry Price
      7-10 days
      Size
      QTY
      SPR-compatible buffer
      TargetMolTargetMolCompare
      HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi), Biotinylated
      RASK2, RALD, NS3, NS, MHC, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-Ras 2, KRAS, KI-RAS, GTPase Kras, C-K-RAS, CFC2
      TMPK-01429
      Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
      • Inquiry Price
      7-10 days
      Size
      QTY
      SPR-compatible buffer
      TargetMolTargetMolCompare
      HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Monomer Protein, Human, MHC (His & Avi)
      RASK2, RALD, NS3, NS, MHC, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-Ras 2, KRAS, KI-RAS, GTPase Kras, C-K-RAS, CFC2
      TMPK-01529
      Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
      • Inquiry Price
      7-10 days
      Size
      QTY
      SPR-compatible buffer
      TargetMolTargetMolCompare
      GADD45A Protein, Human, Recombinant (His & GST)
      growth arrest and DNA-damage-inducible, α, growth arrest and DNA-damage-inducible, alpha, GADD45, DDIT1
      TMPY-02150
      Expression system: Baculovirus Insect Cells
      Length: 1-165, Full Length
      Activity: Not Tested
      • Inquiry Price
      7-10 days
      Size
      QTY
      TargetMolTargetMolCompare
      GADD45G Protein, Human, Recombinant
      GRP17, growth arrest and DNA-damage-inducible, γ, growth arrest and DNA-damage-inducible, gamma, GADD45γ, GADD45gamma, DDIT2, CR6
      TMPY-03655
      Expression system: E. coli
      Length: 1-159, Full Length
      Activity: Not Tested
      • Inquiry Price
      7-10 days
      Size
      QTY
      SPR-compatible buffer
      TargetMolTargetMolCompare
      HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Tetramer Protein, Human, MHC (His & Avi), PE-Labeled
      RASK2, RALD, NS3, NS, MHC, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-Ras 2, KRAS, KI-RAS, GTPase Kras, C-K-RAS, CFC2
      TMPK-01439
      Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
      • Inquiry Price
      7-10 days
      Size
      QTY
      TargetMolTargetMolCompare
      HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
      RASK2, RALD, NS3, NS, MHC, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-Ras 2, KRAS, KI-RAS, GTPase Kras, C-K-RAS, CFC2
      TMPK-01537
      Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
      • Inquiry Price
      7-10 days
      Size
      QTY
      SPR-compatible buffer
      TargetMolTargetMolCompare
      Trypsin-1 Protein, Gadus morhua, Recombinant (His)
      Trypsin-1, Trypsin I
      TMPH-00764
      Expression system: E. coli
      Length: 20-241, Full Length of Mature Protein
      Activity: Not Tested
      • Inquiry Price
      20 days
      Size
      QTY
      TargetMolTargetMolCompare
      GADD45B Protein, Human, Recombinant (His)
      Negative Growth Regulatory Protein MyD118, Myeloid Differentiation Primary Response Protein MyD118, MYD118, Growth Arrest and DNA Damage-Inducible Protein GADD45 β, Growth Arrest and DNA Damage-Inducible Protein GADD45 Beta, GADD45B
      TMPJ-00700
      Growth Arrest and DNA Damage-Inducible Protein GADD45 β (GADD45B) is a member of the GADD45 family. GADD45B has been shown to interact with MAP3K4, ASK1, MAP2K7, and GADD45GIP1. GADD45B is involved in the regulation of growth and apoptosis. GADD45B reacts to environmental stresses by mediating activation of stress-responsive MTK1 MEKK4 kinase, which is an upstream activator of both p38 and JNK MAPKs. In addition, GADD45B participates in the down-regulation of hepatocellular carcinoma (HCC). It may serve as a possible therapeutic target.
      • Inquiry Price
      7-10 days
      Size
      QTY
      TargetMolTargetMolCompare
      HLA-A*11:01&B2M&KRAS G12D (VVGADGVGK) Monomer Protein, Human, MHC (His & Avi)
      RASK2, RALD, NS3, NS, MHC, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-Ras 2, KRAS, KI-RAS, GTPase Kras, C-K-RAS, CFC2
      TMPK-01428
      Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
      • Inquiry Price
      7-10 days
      Size
      QTY
      SPR-compatible buffer
      TargetMolTargetMolCompare
      HLA-C*03:04&B2M&KRAS G12D (GADGVGKSAL) Monomer Protein, Human, MHC (His & Avi), Biotinylated
      RASK2, RALD, NS3, NS, MHC, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-Ras 2, KRAS, KI-RAS, GTPase Kras, C-K-RAS, CFC2
      TMPK-01450
      Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
      • Inquiry Price
      7-10 days
      Size
      QTY
      SPR-compatible buffer
      TargetMolTargetMolCompare
      HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Tetramer Protein, Human, MHC (His & Avi)
      RASK2, RALD, NS3, NS, MHC, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-Ras 2, KRAS, KI-RAS, GTPase Kras, C-K-RAS, CFC2
      TMPK-01507
      Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
      • Inquiry Price
      7-10 days
      Size
      QTY
      SPR-compatible buffer